Hussman Strategic Advisors’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-12,600
Closed -$4.1M 251
2024
Q1
$4.1M Buy
12,600
+2,100
+20% +$516K 0.95% 21
2023
Q4
$2M Hold
10,500
0.45% 87
2023
Q3
$2.09M Buy
10,500
+1,140
+12% +$270K 0.4% 101
2023
Q2
$2.67M Buy
9,360
+3,160
+51% +$878K 0.49% 60
2023
Q1
$1.34M Buy
+6,200
New +$1.21M 0.21% 185

Other funds holding SWAV

Hussman Strategic Advisors's SWAV Position: Q2 2024 in Review

Hussman Strategic Advisors sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 12,600 shares — an estimated $4.1M sold.

Hussman Strategic Advisors first reported a position in SWAV in Q1 2023 and held it in 5 quarters. The position peaked at $4.1M in Q1 2024. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Hussman Strategic Advisors reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Hussman Strategic Advisors sold 12,600 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $4.1M.
  • Hussman Strategic Advisors first reported a position in Shockwave Medical, Inc. Common Stock in Q1 2023 and held it in 5 quarters.
  • Hussman Strategic Advisors's Shockwave Medical, Inc. Common Stock position peaked at $4.1M in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Hussman Strategic Advisors's 13F filing for Q2 2024, filed 1 Aug 2024.